tradingkey.logo

Alpha Tau Medical Ltd

DRTS
5.080USD
-0.020-0.39%
Close 12/23, 16:00ETQuotes delayed by 15 min
433.14MMarket Cap
LossP/E TTM

Alpha Tau Medical Ltd

5.080
-0.020-0.39%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Alpha Tau Medical Ltd

Currency: USD Updated: 2025-10-27

Key Insights

Its valuation is considered undervalued, Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at max_target_price.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Alpha Tau Medical Ltd's Score

Industry at a Glance

Industry Ranking
154 / 204
Overall Ranking
428 / 4682
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Strong Buy
Current Rating
8.500
Target Price
+118.51%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Alpha Tau Medical Ltd Highlights

StrengthsRisks
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Undervalued
The company’s latest PE is -8.61, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.93M shares, increasing 4.40% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 29.40K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.42.

Financial Health

Currency: USD Updated: 2025-10-27

No financial score is currently available for Alpha Tau Medical Ltd. The Healthcare Equipment & Supplies industry's average is 7.47.

Score

Industry at a Glance

Previous score
0.00
Change
0

Financials

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

Operational Efficiency

Growth Potential

Shareholder Returns

Alpha Tau Medical Ltd's Company Valuation

Currency: USD Updated: 2025-10-27

The current valuation score of Alpha Tau Medical Ltd is 7.20, ranking industry_rank/industry_total in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -8.61, which is -38.51% below the recent high of -5.29 and -8.41% above the recent low of -9.33.

Score

Industry at a Glance

Previous score
7.20
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 154/204
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-10-27

The current earnings forecast score of Alpha Tau Medical Ltd is 9.00, ranking industry_rank/industry_total in the Healthcare Equipment & Supplies industry. The average price target for Alpha Tau Medical Ltd is 8.50, with a high of 12.00 and a low of 5.00.

Score

Industry at a Glance

Previous score
9.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts
Strong Buy
Current Rating
8.500
Target Price
+118.51%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

90
Total
4
Median
7
Average
Company name
Ratings
Analysts
Alpha Tau Medical Ltd
DRTS
4
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
34
Intuitive Surgical Inc
ISRG
34
Thermo Fisher Scientific Inc
TMO
27
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-27

The current price momentum score of Alpha Tau Medical Ltd is 6.93, ranking industry_rank/industry_total in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 4.65 and the support level at 3.71, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
7.18
Change
-0.25

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.149
Buy
RSI(14)
65.940
Neutral
STOCH(KDJ)(9,3,3)
87.298
Overbought
ATR(14)
0.378
High Vlolatility
CCI(14)
72.399
Neutral
Williams %R
7.453
Overbought
TRIX(12,20)
1.246
Sell
StochRSI(14)
46.792
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
5.026
Buy
MA10
4.954
Buy
MA20
4.409
Buy
MA50
4.124
Buy
MA100
3.893
Buy
MA200
3.369
Buy

Institutional Confidence

Currency: USD Updated: 2025-10-27

The current institutional shareholding score of Alpha Tau Medical Ltd is 3.00, ranking industry_rank/industry_total in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 2.27%, representing a quarter-over-quarter decrease of 93.45%. The largest institutional shareholder is James Simons, holding a total of 29.40K shares, representing 0.03% of shares outstanding, with 40.65% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Oramed Pharmaceuticals Inc
14.11M
--
Sofer (Uzi)
11.52M
--
Avruch (Michael)
1.55M
+0.17%
Hightower Advisors, LLC
686.55K
+197.59%
Keisari (Yona)
504.27K
+0.16%
HoyleCohen, LLC
269.09K
--
Levin Capital Strategies, L.P.
192.51K
-13.48%
Kovitz Investment Group Partners, LLC
204.83K
-9.49%
Mariner Wealth Advisors
43.12K
+7.48%
Milch (David Mark)
88.74K
-2.20%
1
2

Risk Assessment

Currency: USD Updated: 2025-10-27

No risk assessment score is currently available for Alpha Tau Medical Ltd. The Healthcare Equipment & Supplies industry's average is 4.64. The company's beta value is 1.08. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
0.00
Change
0
Beta vs S&P 500 index
1.03
VaR
--
240-Day Maximum Drawdown
+41.67%
240-Day Volatility
+74.76%

Return

Best Daily Return
60 days
+19.62%
120 days
+19.62%
5 years
--
Worst Daily Return
60 days
-7.19%
120 days
-8.71%
5 years
--
Sharpe Ratio
60 days
+1.51
120 days
+1.97
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+41.67%
3 years
+57.42%
5 years
+100.00%
Return-to-Drawdown Ratio
240 days
+1.25
3 years
+0.22
5 years
-0.09
Skewness
240 days
+0.87
3 years
+0.92
5 years
--

Volatility

Realised Volatility
240 days
+74.76%
5 years
--
Standardised True Range
240 days
+4.21%
5 years
+6.45%
Downside Risk-Adjusted Return
120 days
+402.07%
240 days
+402.07%
Maximum Daily Upside Volatility
60 days
+64.62%
Maximum Daily Downside Volatility
60 days
+45.99%

Liquidity

Average Turnover Rate
60 days
+0.07%
120 days
+0.06%
5 years
--
Turnover Deviation
20 days
+41.80%
60 days
+13.35%
120 days
+1.36%

Peer Comparison

Healthcare Equipment & Supplies
Alpha Tau Medical Ltd
Alpha Tau Medical Ltd
DRTS
4.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
Tactile Systems Technology Inc
TCMD
8.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.41 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Alpha Tau Medical Ltd?

The TradingKey Stock Score provides a comprehensive assessment of Alpha Tau Medical Ltd based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Alpha Tau Medical Ltd’s performance and outlook.

How do we generate the financial health score of Alpha Tau Medical Ltd?

To generate the financial health score of Alpha Tau Medical Ltd, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Alpha Tau Medical Ltd's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Alpha Tau Medical Ltd.

How do we generate the company valuation score of Alpha Tau Medical Ltd?

To generate the company valuation score of Alpha Tau Medical Ltd, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Alpha Tau Medical Ltd’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Alpha Tau Medical Ltd’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Alpha Tau Medical Ltd.

How do we generate the earnings forecast score of Alpha Tau Medical Ltd?

To calculate the earnings forecast score of Alpha Tau Medical Ltd, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Alpha Tau Medical Ltd’s future.

How do we generate the price momentum score of Alpha Tau Medical Ltd?

When generating the price momentum score for Alpha Tau Medical Ltd, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Alpha Tau Medical Ltd’s prices. A higher score indicates a more stable short-term price trend for Alpha Tau Medical Ltd.

How do we generate the institutional confidence score of Alpha Tau Medical Ltd?

To generate the institutional confidence score of Alpha Tau Medical Ltd, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Alpha Tau Medical Ltd’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Alpha Tau Medical Ltd.

How do we generate the risk management score of Alpha Tau Medical Ltd?

To assess the risk management score of Alpha Tau Medical Ltd, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Alpha Tau Medical Ltd’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Alpha Tau Medical Ltd.
KeyAI